Navigation Links
Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
Date:5/14/2009

VEENENDAAL, The Netherlands, May 14 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, today announced a new release of Oncentra(R) Brachy, a comprehensive film- and volume-based treatment planning system to optimize cancer treatment planning for brachytherapy. Oncentra Brachy, the world's first fully DICOM-compatible treatment planning system, is a user-friendly Windows-based planning system that features state-of-the-art optimization algorithms to ensure efficient treatment.

Oncentra Brachy is adaptable to any clinical workflow. As well as advanced 3D contouring and margining tools, Oncentra Brachy fully supports film-based (2D) treatment planning. The system allows for planning of a wide variety of brachytherapy treatments. Oncentra Brachy is fully geared up towards Intensity Modulated Brachytherapy (IMBT).

"We have set a new benchmark in brachytherapy treatment planning," said Jos Lamers, chief executive officer of Nucletron. "We have worked with our clinical partners to develop a solution that migrates PLATO users to a new platform that fits the demands of all clinics. As part of our full range of brachytherapy solutions, Oncentra Brachy is a key element of our efforts in improving patient care."

Nucletron will display and demonstrate Oncentra Brachy throughout the 2009 GEC ESTRO in Porto, Portugal, from 13 to 16 May 2009, and at ABS 2009 in Toronto, Canada, from 31 May to 2 June 2009.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between
'/>"/>

SOURCE Nucletron B V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nucletron Announces 2008 Results
2. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
3. Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
4. ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA
5. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
6. STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL
7. Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft
8. Cancer Clinics of Excellence (CCE) Releases 62nd Evidence-Based Treatment Protocol
9. ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes
10. Polymer Science Releases New Silicone Gel Adhesive Products for MD&M West
11. Coalition for the Advancement of Medical Research Releases New White Paper, Catalyst for Cures: Embryonic Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
(Date:12/15/2009)... Prinz Law Office has announced the launch of several ... secure legal services in the current economic climate. ... the opportunity to finance legal services over a period ... any equity in their start-up companies. The second ... fixed montly payment arrangements over 6 to 12 month ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... 11 Mentice AB, a leading,supplier of virtual reality ... appointed James Ruscoe as Chairman of the Board and,Goran ... Ruscoe graduated from Oxford University and brings with him ... serves as CEO and,board member of several Swiss private ...
... The Project on Emerging Nanotechnologies (PEN) and National ... premiere event for the television series Nanotechnology: The ... The eventby invitation onlywill include remarks by U.S. ... Congressional Nanotechnology Caucus. , The series three programs ...
... Halozyme,Therapeutics, Inc. (Nasdaq: HALO ), a ... the extracellular matrix, today,announced new safety and ... for its recombinant human PH20 enzyme (rHuPH20). ... the European Federation for,Pharmaceutical Sciences meeting for ...
Other Biology Technology:Mentice AB Announces Leadership Changes Within Its Worldwide Operations 2New nanotechnology television series does 'sweat the small stuff' 2Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences 2Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences 3Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences 4
(Date:12/14/2009)... fuel that could help wean the nation from oil, ... with gasoline, especially in winter, according to a new ... from both gasoline and E85, a blend of gasoline ... in warm sunny weather than during the cold weather ... contribute to ozone formation. But E85 produces different byproducts ...
(Date:12/14/2009)... from the Astrobiology Centre (INTA-CSIC) has shown that hydrogen ... formation of the most basic biological molecules can be ... carry out this study, published in the journal ... conditions of the early Earth. , "We have shown ... it produces hydrogen cyanide, a substance that could have ...
(Date:12/13/2009)... plant enzymes that may help to engineer plants that ... more efficiently. The finding could help to engineer crops ... take in the carbon dioxide they need for photosynthesis ... But for each molecule of the gas gained, they ... The pores can tighten to save water when CO ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3Prussian blue linked to the origin of life 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Angelo Masciantonio CEO and Co Founder of HTH Worldwide Named Ernst 26 Young 2009 Entrepreneur Of The Year 28R 29 in Greater Philadelphia 49804 1Angelo Masciantonio CEO and Co Founder of HTH Worldwide Named Ernst 26 Young 2009 Entrepreneur Of The Year 28R 29 in Greater Philadelphia 49804 2Angelo Masciantonio CEO and Co Founder of HTH Worldwide Named Ernst 26 Young 2009 Entrepreneur Of The Year 28R 29 in Greater Philadelphia 49804 3Spherix Announces Termination of Arla License Agreement 12752 1Spherix Announces Termination of Arla License Agreement 12752 2Spherix Announces Termination of Arla License Agreement 12752 3Spherix Announces Termination of Arla License Agreement 12752 4New Online Company Is Helping to Bring a Solution to the Increasingly Devastating Problem of Healthcare Costs in America at No Cost to Consumers 49798 1New Online Company Is Helping to Bring a Solution to the Increasingly Devastating Problem of Healthcare Costs in America at No Cost to Consumers 49798 2
... is a Swiss success story at the frontier of biology ... 25 working groups, one of which has just made a ... , The SIB is backed by some of the best ... by the Swiss government as well as international agencies, the ...
... First Such Board on the Market, Stantum,s SMK ... Their Own Resistive Multi-Touch Applications, SAN DIEGO, ... pioneer developer of multi-touch sensing,technology, today introduced a ... PMatrix(TM) resistive multi-touch technology, which lets,users simultaneously move ...
... A new study finds that environmental restoration research using ... in Restoration Ecology, maintains that for restoration ... research should be done on whole ecosystems with large ... of large restoration sites by conducting large-scale experiments," says ...
Other Biology News:Swiss Institute of Bioinformatics celebrates 10th birthday by presenting major gifts to human health 2Swiss Institute of Bioinformatics celebrates 10th birthday by presenting major gifts to human health 3Swiss Institute of Bioinformatics celebrates 10th birthday by presenting major gifts to human health 4Swiss Institute of Bioinformatics celebrates 10th birthday by presenting major gifts to human health 5Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology 2Lack of large-scale experiments slows progress of environmental restoration 2
Complete PCR kit. Includes: MasterAmp™ Taq DNA Polymerase, 10X PCR Buffer, MasterAmp™ 10X PCR Enhancer, dNTP Mix, 2.5 mM each, 25 mM MgCl2, Enzyme Dilution Buffer, Control Template and Prim...
Rabbit polyclonal to 3-Ethynylestradiol ( Abpromise for all tested applications). Antigen: Ethynylestradiol conjugated to BSA....
... 2b GenBank Accession Number ... peptide (C-QSQENQDTRPKVKAKK), corresponding to amino ... 2b Formulation: antiserum in 0.05% ... Quality Assurance: routinely evaluated by ...
Raised to 5-HIAA coupled to BSA with paraformaldehyde....
Biology Products: